These trials completed more than 12 months ago and should have reported results.

These trials are not yet due to report results: some are ongoing, some completed within the past 12 months.

These trials have problematic data on the registry. Details why »

Status Trial ID Title Completion date Category
Reported results 2016-002067-33 COBALT: Coversin Global Study: An Open-Label, Safety and Efficacy Trial in PNH Patients 2017-12-21 due-trials
Reported results Terminated 2016-004129-18 CONSERVE: Coversin Long Term Safety and Efficacy Surveillance Study 2020-06-22 due-trials
Reported results Terminated 2017-000064-15 A Phase 2, single arm study of Safety and Efficacy of Coversin in adult aHUS subjects 2019-04-17 due-trials
Exempt, with results Terminated 2017-002835-40 Topical rVA576 for treatment of atopic keratoconjunctivitis: a randomised placebo double masked parallel trial (TRACKER) rVA576 tópico para el tratamiento de la queratoconjuntivitis atópica: un ens... 2020-12-15 not-yet-due
Reported results 2017-002836-18 A Phase IIa open label single arm study of safety and efficacy of rVA576 in adult mild to moderate Bullous Pemphigoid subjects 2020-04-29 due-trials
Reported results 2017-003847-39 CAPSTONE: Phase III Confirmatory Assessment Protocol: rVA576 Safety and Efficacy in Three-Part, Two-Arm, Randomised Open Label Evaluation in patients with Paroxysmal Nocturnal Haemoglobinuria (PNH) 2020-09-03 due-trials
Other 2020-000086-17 Multicentre Study of nomacopan in Paediatric Haematopoietic Stem-Cell Transplant Associated Thrombotic Microangiopathy not-yet-due
Ongoing, reported early 2020-005987-67 A randomized, part A partial blinded and part B double blinded, placebo-controlled 24-week clinical study to evaluate the efficacy and safety of nomacopan therapy in adult patients with bullous pemphi... not-yet-due